SCHEMBL4896183

SCHEMBL4896183

COc1ccc(C=C(C(=O)O)C(C)C(C)OC)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.45
ATM Q13315 1/20 0.45
AKR1C3 P42330 1/20 0.44
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
F3 P13726 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
NFKB1 P19838 2/20 0.41
TSHR P16473 1/20 0.41
APEX1 P27695 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GSK3B P49841 2/20 0.41
BACE1 P56817 1/20 0.41
CYP2A6 P11509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4896165 1.00 THRB (0.45) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL4879128 0.84 THRB (0.50) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL4906426 0.84 THRB (0.50) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL490213 0.84 THRB (0.50) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL8153615 0.81 CYP1A2 (0.52) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL16266991 0.80 THRB (0.49) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL5085450 0.77 THRB (0.43) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL4896172 0.75 LMNA (0.48) THRBATMAKR1C3ALDH1A1KDM4E
SCHEMBL16160027 0.74 ALDH1A1 (0.49) THRBATMALDH1A1KDM4EMAPT
SCHEMBL7820839 0.73 THRB (0.56) THRBATMAKR1C3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242876-A1 Process For the Manufacture of Substituted Propionic Acids PHOENIX CHEMICALS LTD. (GB) 2008-10-02 US disclosed
EP-1838654-A1 PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS Phoenix Chemicals Limited (GB) 2007-10-03 EP disclosed
WO-2006075177-A1 PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS PHOENIX CHEMICALS LTD. (GB) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242876-A1 Process For the Manufacture of Substituted Propionic Acids AS3MT, PPA1, AGPS THRB 1198/4885ATM 3608/4885AKR1C3 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.